首页> 美国卫生研究院文献>Case Reports in Pulmonology >Development of Bullous Disease during Treatment of Pulmonary Marginal Zone B-Cell Lymphoma
【2h】

Development of Bullous Disease during Treatment of Pulmonary Marginal Zone B-Cell Lymphoma

机译:肺边缘区B细胞淋巴瘤治疗期间大疱性疾病的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe an unusual case of severe pulmonary bullous disease developing during treatment of marginal zone B-Cell lymphoma (MALT) involving the pulmonary parenchyma. The patient originally presented with pneumonia-like symptoms along with hemoptysis and was diagnosed with MALT lymphoma after a video-assisted thoracic surgical (VATS) lung biopsy. Computed tomography (CT) of the chest at diagnosis revealed multiple opacities, but no bullous disease. During the ensuing 4 years, and while on chemotherapy for the MALT lymphoma, sequential CT and pulmonary function tests revealed the development of progressive bullous disease resulting in the replacement of large portions of the lung parenchyma with bilateral bullae. This complication is rare, has been reported only once before in a patient with concomitant amyloidosis, and may be related to activation of proteolytic enzymes by lymphoma cells or chemotherapeutic agents.
机译:我们描述了在边缘区域B细胞淋巴瘤(MALT)累及肺实质的过程中发展成的严重肺大疱性疾病的罕见病例。该患者最初出现肺炎样症状并伴有咯血,经电视胸腔镜手术(VATS)肺活检后被确诊为MALT淋巴瘤。诊断时胸部的计算机断层扫描(CT)显示多处混浊,但无大疱性疾病。在随后的4年中,以及在对MALT淋巴瘤进行化学疗法时,连续的CT和肺功能测试显示进展性大疱性疾病的发展,导致大部分肺实质被双侧大疱性肺炎所取代。这种并发症很少见,在淀粉样变性伴发患者中仅报道过一次,可能与淋巴瘤细胞或化学治疗剂激活蛋白水解酶有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号